Claudin18.2 as a Promising Therapeutic Target in Gastric Cancer.

Cells · 2025 · PMC12384651 · PMID 40862764

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

IMC002 is presented in the form of autologous cell therapy, which includes the VHH antibody that is characterized by quite significant specificity.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.